Exact Mass: 482.0697
Exact Mass Matches: 482.0697
Found 153 metabolites which its exact mass value is equals to given mass value 482.0697
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
3'-(2'-Galloylglucosyl)-phloroacetophenone
3-(2-Galloylglucosyl)-phloroacetophenone is found in herbs and spices. 3-(2-Galloylglucosyl)-phloroacetophenone is a constituent of Syzygium aromaticum (clove). Constituent of Syzygium aromaticum (clove). 3-(2-Galloylglucosyl)-phloroacetophenone is found in herbs and spices.
3,4,5,11,12,13,21,22,23-nonahydroxy-9,14,17-trioxatetracyclo[17.4.0.0(2),.0(1),(1)]tricosa-1(23),2,4,6,19,21-hexaene-8,18-dione
3'-(6'-Galloylglucosyl)-phloroacetophenone
3-(6-Galloylglucosyl)-phloroacetophenone is found in herbs and spices. 3-(6-Galloylglucosyl)-phloroacetophenone is a constituent of Syzygium aromaticum (clove). Constituent of Syzygium aromaticum (clove). 3-(6-Galloylglucosyl)-phloroacetophenone is found in herbs and spices.
6,7,8,11,12,13,21,22,23-nonahydroxy-2,17,20-trioxatetracyclo[17.3.1.0,.0(1),(1)]tricosa-4,6,8,10,12,14-hexaene-3,16-dione
(-)-Epigallocatechin 3'-glucuronide
(-)-Epigallocatechin 3-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
(-)-Epigallocatechin 3-glucuronide
(-)-Epigallocatechin 3-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
(-)-Epigallocatechin 7-glucuronide
(-)-Epigallocatechin 7-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Regorafenib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Regorafenib (BAY 73-4506) is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib shows very robust antitumor and antiangiogenic activity[1].
Seletalisib
3,4,2,3,4,6,alpha-Heptahydroxychalcone 2-glucoside
2-(alpha-Hydroxypropyl)thiamine diphosphate; 2-Hydroxypropyl-ThPP
5,6,7,8,2,5-hexahydroxy-4-methoxyflavanone-beta-D-xylopyranoside
5-O-(6-galloyl)-beta-D-glucopyranosyl methyl gentisate|rubrumoside B
4,6-(S)-HHDP-D-glucose|4,6-O-((S)-4,4,5,5,6,6-hexahydroxydiphenoyl)-D-glucose|4,6-O-<(S)-4,4,5,5,6,6-hexahydroxydiphenoyl>-D-glucose
glucopyranosyl 2-O-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxyphenylacetate
Cys Cys Glu Glu
Cys Asp Asp Met
Cys Asp Met Asp
Cys Glu Cys Glu
Cys Glu Glu Cys
Cys Met Asp Asp
Asp Cys Asp Met
Asp Cys Met Asp
Asp Asp Cys Met
Asp Asp Met Cys
Asp Met Cys Asp
Asp Met Asp Cys
Glu Cys Cys Glu
Glu Cys Glu Cys
Glu Glu Cys Cys
Met Cys Asp Asp
Met Asp Cys Asp
Met Asp Asp Cys
3'-(2''-Galloylglucosyl)-phloroacetophenone
3'-(6''-Galloylglucosyl)-phloroacetophenone
(-)-Epigallocatechin 3'-glucuronide
(-)-Epigallocatechin 3-glucuronide
(-)-Epigallocatechin 7-glucuronide
2-(4-Iodophenyl)-4,5-bis(4-methoxyphenyl)-1H-imidazole
Ferrous gluconate dihydrate
B - Blood and blood forming organs > B03 - Antianemic preparations > B03A - Iron preparations > B03AA - Iron bivalent, oral preparations D006401 - Hematologic Agents > D006397 - Hematinics
2-Naphthalenesulfonic acid, 6-hydroxy-5-[2-(2-methoxy-5-methyl-4- sulfophenyl)diazenyl]-, aluminum salt (1:1)
Raltegravir potassium
D004791 - Enzyme Inhibitors > D019429 - Integrase Inhibitors > D019428 - HIV Integrase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent
cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl-4-methylbenzenesulphonate
[3,3,4,4,5,5,6,6,7,8,8,8-dodecafluoro-7-(trifluoromethyl)octyl] 2-methylprop-2-enoate
2-(4-(2-((3-(5-(Pyridin-2-Ylthio)thiazol-2-Yl)ureido)methyl)-1h-Imidazol-4-Yl)phenoxy)acetic Acid
Regorafenib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Regorafenib (BAY 73-4506) is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib shows very robust antitumor and antiangiogenic activity[1].
2,3-Dihydroxybenzoyl 5-adenylate(1-)
Conjugate base of 2,3-dihydroxybenzoyl 5-adenylate.
3-(O-beta-glucosyl)-dioxindole-3-acetyl-aspartic acid
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 3-amino-4-hydroxybenzoate
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-4-({[3-methyl-1-(4-methylphenyl)-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]methyl}amino)benzenesulfonamide
2-[(2,6-dichlorophenyl)sulfonylamino]-3-methylbutanoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester
(E)-2-cyano-N-(1,1-dioxothiolan-3-yl)-3-[2-(4-fluorophenoxy)-9-methyl-4-oxopyrido[1,2-a]pyrimidin-3-yl]prop-2-enamide
2-Phenyl-5-thiophen-2-yl-3-pyrazolecarboxylic acid [2-(4-chloro-3-nitroanilino)-2-oxoethyl] ester
2-Phenyl-5-thiophen-2-yl-3-pyrazolecarboxylic acid [2-(2-chloro-5-nitroanilino)-2-oxoethyl] ester
2-[1-(4-chlorophenyl)-5-oxo-3-(2-pyridin-4-ylethyl)-2-sulfanylidene-4-imidazolidinyl]-N-(4-fluorophenyl)acetamide
6-Bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(thiophen-2-ylthio)methyl]-3-indolecarboxylic acid ethyl ester
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,3R,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,3S,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,3S,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,3S,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,3S,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,3R,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,3R,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetamide
2-hydroxy-4-[4-[(5Z)-5-[(Z)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid
[2-[5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxyoxan-3-yl] hydrogen sulate
[2-(acetyloxy)-2-(9-{[(2E)-2-methylbut-2-enoyl]oxy}-2-oxo-2H,8H,9H-furo[2,3-h]chromen-8-yl)propoxy]sulfonic acid
2-(2,5-dihydroxy-4-methoxyphenyl)-5,6,8-trihydroxy-7-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3-dihydro-1-benzopyran-4-one
(7r,8s,8as)-8-hydroxy-7-methyl-6-oxo-3-[(1e)-prop-1-en-1-yl]-8,8a-dihydro-1h-isochromen-7-yl 3,5-dichloro-2,4-dimethoxy-6-methylbenzoate
7,7'-dihydroxy-3-[(2-oxochromen-7-yl)oxy]-[8,8'-bichromene]-2,2'-dione
(10r,11r,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaene-8,17-dione
(10r,11s,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaene-8,17-dione
2,3-hexahydroxydiphenyl-D-glucose
{"Ingredient_id": "HBIN004100","Ingredient_name": "2,3-hexahydroxydiphenyl-D-glucose","Alias": "NA","Ingredient_formula": "C20H18O14","Ingredient_Smile": "C1=C2C(=C(C(=C1O)O)O)C3=C(C(=C(C=C3C(=O)OC4C(C(C(OC4O)CO)O)OC2=O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42628","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2,3-o-(s)-hexahydroxydiphenoyl-d-gluco-pyranose
{"Ingredient_id": "HBIN004147","Ingredient_name": "2,3-o-(s)-hexahydroxydiphenoyl-d-gluco-pyranose","Alias": "NA","Ingredient_formula": "C20H18O14","Ingredient_Smile": "C1=C2C(=C(C(=C1O)O)O)C3=C(C(=C(C=C3C(=O)OC4C(C(C(OC4O)CO)O)OC2=O)O)O)O","Ingredient_weight": "482.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15749","TCMID_id": "9501","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "14035453","DrugBank_id": "NA"}